Parian Global Management »

Peregrine Pharmaceuticals shares owned by Parian Global Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Parian Global Management from 13F filings

Historical chart of Parian Global Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Parian Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Parian Global Management

Quarter filed Position value Share count Share price at filing
2022-09-30 $593k 31k 19.13

More positions owned by Parian Global Management

CVRX (CVRX)
Apollo Endosurgery
Irhythm Technologies (IRTC)
Neuronetics (STIM)
Alphatec Hldgs Com New (ATEC)
Inotiv (NOTV)
Vapotherm
Stereotaxis Com New (STXS)
Oncology Institu (TOI)
Airsculpt Technologies (AIRS)
Natera (NTRA)
Alpha Teknova (TKNO)
Viewray (VRAYQ)
Acv Auctions Com Cl A (ACVA)
Griffon Corporation (GFF)

View all positions for Parian Global Management

Top funds holding Peregrine Pharmaceuticals

BlackRock
Millennium Management
Vanguard Group
Point72 Asset Management
AltraVue Capital
State Street Corporation
Punch & Associates Investment Management
Royal Bank of Canada
First Light Asset Management
Portolan Capital Management
Palisade Capital Management
Snyder Capital Management
Geode Capital Management
Emerald Advisers
Citadel Advisors

View all funds holding Peregrine Pharmaceuticals